1. Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis
   Shinsuke Kazama et al, 2018, Asian Journal of Surgery CrossRef
2. High expression of CD133 – stem cell marker for prediction of clinically agressive type of colorectal cancer
   Ognen Kostovski et al, 2020, Polish Journal of Surgery CrossRef
3. AC133 expression associated with poor prognosis in stage II colorectal cancer
   Xiaofang Ying et al, 2013, Medical Oncology CrossRef
4. Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
   Kousuke Hashimoto et al, 2014, Gastric Cancer CrossRef
5. Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer
   Tatsuzo Mizukami et al, 2018, Oncology Letters CrossRef
6. Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin
   Małgorzata Przybyszewska et al, 2017, Archivum Immunologiae et Therapiae Experimentalis CrossRef
7. Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
   Ke Wang et al, 2012, BMC Cancer CrossRef
8. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
   Philipp Grosse‐Gehling et al, 2013, The Journal of Pathology CrossRef
9. Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
   Kristel Kemper et al, 2012, Clinical Cancer Research CrossRef
10. The expression levels and clinical significance of MFG-E8 and CD133 in epithelial ovarian cancer
    Na Li et al, 2020, Gynecological Endocrinology CrossRef
11. Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps
    Chih-Yung Yang et al, 2015, International Journal of Colorectal Disease CrossRef
12. CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
    Shicai Chen et al, 2013, PLoS ONE CrossRef
13. WBSCR22 Competes with Long Non-coding RNA Linc00346 for miR-509-5p Binding Site to Regulate Cancer Stem Cell Phenotypes of Colorectal Cancer
    Haiyan Zhao et al, 2020, Biochemical Genetics CrossRef
14. CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients
    Rongyong Huang et al, 2018, Medicine CrossRef
15. Impact of Chronic Kidney Disease on Clinical Outcomes of Endovascular Treatment for Femoropopliteal Arterial Disease
    Paul P. Heideman et al, 2016, Journal of Vascular and Interventional Radiology CrossRef
16. Cancer Stem Cells as a Predictive Factor in Radiotherapy
    Thomas B. Brunner et al, 2012, Seminars in Radiation Oncology CrossRef
17. Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
    Youn Young Park et al, 2019, Medicine CrossRef
18. Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: Effects associated with STAT3/Survivin
    Kunming Wen et al, 2013, Cancer Letters CrossRef
19. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals
    L. Cortes-Dericks et al, 2012, European Journal of Cardio-Thoracic Surgery CrossRef
20. CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells
    Celia Chao et al, 2012, Laboratory Investigation CrossRef
21. Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas
    Iva Zambo et al, 2016, Cancer Biomarkers CrossRef
22. Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo
    Susann Peickert et al, 2012, Laboratory Investigation CrossRef
23. Prediction in Rectal Cancer
    Eliane C.M. Zeestraten et al, 2012, Seminars in Radiation Oncology CrossRef
24. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro
    YONGCHENG WANG et al, 2015, Molecular Medicine Reports CrossRef
25. Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
    Xintao Li et al, 2015, Scientific Reports CrossRef